Results 151 to 160 of about 4,291,624 (296)

Portuguese version of the CDR plus NACC FTLD: Validation studies. [PDF]

open access: yesAlzheimers Dement (Amst), 2022
Lima M   +7 more
europepmc   +1 more source

The PI3Kδ inhibitor roginolisib (IOA‐244) preserves T‐cell function and activity

open access: yesMolecular Oncology, EarlyView.
Identification of novel PI3K inhibitors with limited immune‐related adverse effects is highly sought after. We found that roginolisib and idelalisib inhibit chronic lymphocytic leukemia (CLL) cells and Treg suppressive functions to similar extents, but roginolisib affects cytotoxic T‐cell function and promotion of pro‐inflammatory T helper subsets to a
Elise Solli   +7 more
wiley   +1 more source

Adaptação transcultural para o português do End of Life Comfort Questionnaire – Patient [Cross-cultural adaptation of the End of Life Comfort Questionnaire-Patient to Brazilian Portuguese]

open access: yesRevista Enfermagem UERJ, 2014
O objetivo foi validar para o português, falado no Brasil, a escala End of life Comfort Questionnaire-Patient. A validação constituiu-se de tradução, síntese, retrotradução, revisão por comitê de especialistas, pré-teste e verificação das propriedades ...
Liana Amorim Corrêa Trotte   +4 more
doaj  

Correlation of the differential expression of PIK3R1 and its spliced variant, p55α, in pan‐cancer

open access: yesMolecular Oncology, EarlyView.
PIK3R1 undergoes alternative splicing to generate the isoforms, p85α and p55α. By combining large patient datasets with laboratory experiments, we show that PIK3R1 spliced variants shape cancer behavior. While tumors lose the protective p85α isoform, p55α is overexpressed, changes linked to poorer survival and more pronounced in African American ...
Ishita Gupta   +10 more
wiley   +1 more source

Basroparib inhibits YAP‐driven cancers by stabilizing angiomotin

open access: yesMolecular Oncology, EarlyView.
Basroparib, a selective tankyrase inhibitor, suppresses Wnt signaling and attenuates YAP‐driven oncogenic programs by stabilizing angiomotin. It promotes AMOT–YAP complex formation, enforces cytoplasmic YAP sequestration, inhibits YAP/TEAD transcription, and sensitizes YAP‐active cancers, including KRAS‐mutant colorectal cancer, to MEK inhibition.
Young‐Ju Kwon   +4 more
wiley   +1 more source

Systematic profiling of conditional degron tag technologies for target validation studies. [PDF]

open access: yesNat Commun, 2022
Bondeson DP   +18 more
europepmc   +1 more source

Cotargeting TREM2 and IL2 pathways triggers multipronged anticancer immunity

open access: yesMolecular Oncology, EarlyView.
Von Locquenghien et al. report that MiTE‐144, a triggering receptor expressed on myeloid cells 2 (TREM2) blocking antibody fused to interleukin‐2 (IL2) variant with tumour microenvironment restricted activation, demonstrates superior anticancer efficiency in a preclinical setting.
Isaure Vanmeerbeek   +2 more
wiley   +1 more source

Validity studies

open access: yesEuropean Psychiatry, 1996
openaire   +1 more source

Home - About - Disclaimer - Privacy